Phreesia, Inc. (PHR) Business Model Canvas

Phreesia, Inc. (PHR): Business Model Canvas

US | Healthcare | Medical - Healthcare Information Services | NYSE
Phreesia, Inc. (PHR) Business Model Canvas

Fully Editable: Tailor To Your Needs In Excel Or Sheets

Professional Design: Trusted, Industry-Standard Templates

Investor-Approved Valuation Models

MAC/PC Compatible, Fully Unlocked

No Expertise Is Needed; Easy To Follow

Phreesia, Inc. (PHR) Bundle

Get Full Bundle:
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$24.99 $14.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99

TOTAL:

In der sich schnell entwickelnden Landschaft der Gesundheitstechnologie entwickelt sich Phreesia, Inc. (PHR) zu einer transformativen Kraft, die durch ihre innovative digitale Plattform die Patientenaufnahme und Verwaltungsprozesse neu definiert. Durch die nahtlose Integration modernster Softwarelösungen in die Arbeitsabläufe von Gesundheitsdienstleistern bietet Phreesia ein umfassendes Ökosystem, das den Verwaltungsaufwand reduziert, die Patienteneinbindung verbessert und den klinischen Betrieb optimiert. Dieser tiefe Einblick in das Business Model Canvas von Phreesia enthüllt die strategische Architektur hinter ihrem bahnbrechenden Ansatz zur Modernisierung von Interaktionen im Gesundheitswesen und bietet Einblicke, wie Technologie das Patientenerlebnis und die Effizienz medizinischer Praxen grundlegend verändern kann.


Phreesia, Inc. (PHR) – Geschäftsmodell: Wichtige Partnerschaften

Anbieter elektronischer Patientenakten (EHR).

Phreesia arbeitet durch strategische Integrationspartnerschaften mit großen EHR-Anbietern zusammen:

EHR-Partner Integrationsstatus Marktanteil
Epische Systeme Direkte API-Integration 29,2 % Marktanteil im Gesundheitswesen
Cerner Corporation Umfassender Datenaustausch 25,6 % Marktanteil im Gesundheitswesen
Allskripte Interoperabilitätsprotokoll 7,3 % Marktanteil im Gesundheitswesen

Anbieter von Gesundheitstechnologie

Zu den wichtigsten Partnerschaften mit Technologieanbietern gehören:

  • Athenahealth – Lösungen zur Patienteneinbindung
  • Kareo – Praxismanagement-Integration
  • eClinicalWorks – Optimierung klinischer Arbeitsabläufe

Unternehmen für Managementsoftware für Arztpraxen

Partner Integrationstyp Jahresumsatz
Übe Fusion Umfassende Software-Integration 100,4 Millionen US-Dollar (2022)
NextGen Healthcare Klinischer Datenaustausch 612 Millionen US-Dollar (2022)

Krankenversicherungsanbieter

Zu den Versicherungspartnerschaften von Phreesia gehören:

  • UnitedHealthcare – Integration der Schadensbearbeitung
  • Cigna – Dienstleistungen zur Patientenverifizierung
  • Aetna – Plattform zur Überprüfung der Berechtigung

Hersteller medizinischer Geräte

Gerätehersteller Partnerschaftsfokus Globale Marktgröße
Medtronic Patienten-Check-in-Integration 30,5 Milliarden US-Dollar (2022)
Philips Healthcare Digitales Patientenmanagement 19,8 Milliarden US-Dollar (2022)

Phreesia, Inc. (PHR) – Geschäftsmodell: Hauptaktivitäten

Softwareentwicklung und Plattformwartung

Phreesia investierte im Geschäftsjahr 2023 73,4 Millionen US-Dollar in Forschungs- und Entwicklungskosten. Das Unternehmen unterhält ein Software-Engineering-Team von etwa 250 Fachleuten, die sich der Plattformentwicklung und -wartung widmen.

Entwicklungsmetrik Daten für 2023
F&E-Ausgaben 73,4 Millionen US-Dollar
Mitarbeiter der Softwareentwicklung 250 Profis
Jährliche Plattform-Updates 4-6 Hauptveröffentlichungen

Innovation in der Patientenaufnahme- und Registrierungstechnologie

Die Patientenaufnahmeplattform von Phreesia bedient jährlich über 97 Millionen Patientenbesuche in über 2.200 Gesundheitsorganisationen.

  • Digitale Patientenregistrierungslösungen werden in 50 Bundesstaaten eingesetzt
  • Durchschnittliche Patienten-Check-in-Zeit um 47 % verkürzt
  • HIPAA-konforme Technologieinfrastruktur

Gesundheitsdatenmanagement und -analyse

Das Unternehmen verarbeitet jährlich etwa 1,2 Milliarden Datenpunkte über seine Healthcare-Engagement-Plattform.

Datenverwaltungsmetrik Jahresvolumen
Verarbeitete Datenpunkte 1,2 Milliarden
Betreute Gesundheitsorganisationen 2,200+
Patientenbesuche verwaltet 97 Millionen

Kundensupport und Implementierungsdienste

Phreesia unterhält ein engagiertes Kundenerfolgsteam mit einer Kundenzufriedenheitsrate von 92 % und einer durchschnittlichen Implementierungszeit von 45 Tagen für neue Kunden im Gesundheitswesen.

  • Technischer Support rund um die Uhr verfügbar
  • Engagierte Implementierungsspezialisten
  • Mehrsprachige Unterstützungsfunktionen

Kontinuierliche Produktverbesserung und Funktionserweiterungen

Im Jahr 2023 veröffentlichte Phreesia sechs große Plattformaktualisierungen mit 18 neuen Funktionserweiterungen, die sich auf die Verbesserung der Patienteneinbindung und der Effizienz der Arbeitsabläufe im Gesundheitswesen konzentrieren.

Produktentwicklungsmetrik Leistung 2023
Wichtige Plattform-Updates 6 Veröffentlichungen
Neue Funktionserweiterungen 18 Funktionen
Investition in Produktinnovation 73,4 Millionen US-Dollar Forschungs- und Entwicklungsbudget

Phreesia, Inc. (PHR) – Geschäftsmodell: Schlüsselressourcen

Proprietäre Softwareplattform für die Patientenaufnahme

Im vierten Quartal 2023 bedient die Softwareplattform von Phreesia über 97.000 Gesundheitsdienstleister in den Vereinigten Staaten.

Plattformmetrik Quantitative Daten
Gesamtheit der Gesundheitsdienstleister 97,000+
Jährliche Patienteninteraktionen 125 Millionen+
Software-Integrationsfunktionen Über 200 Systeme zur elektronischen Gesundheitsakte (EHR).

Fachwissen im Bereich Gesundheitstechnologie

Das Technologieteam von Phreesia besteht zum 31. Dezember 2023 aus 382 Vollzeitmitarbeitern, die auf die Entwicklung von Gesundheitssoftware spezialisiert sind.

Große Datenbank mit Informationen zur Patientenaufnahme

  • Aggregiertes Patientendatenvolumen: über 550 Millionen Patienteninteraktionen
  • Datenschutzkonformität: HIPAA- und HITRUST-zertifiziert
  • Datenverarbeitungsfunktionen in Echtzeit

Starkes Engineering- und Entwicklungsteam

Teamzusammensetzung Nummer
Gesamtes technisches Personal 187
Produktentwicklungsingenieure 124
Software-Qualitätssicherung 63

Cloudbasierte Infrastruktur und Technologie

Infrastrukturinvestitionen im Jahr 2023: 24,3 Millionen US-Dollar für die Entwicklung von Cloud-Technologie und Infrastruktur.

Cloud-Infrastruktur-Metrik Spezifikation
Cloud-Dienstanbieter Amazon Web Services (AWS)
Jährliche Ausgaben für Cloud-Technologie 24,3 Millionen US-Dollar
Systemverfügbarkeit 99.99%

Phreesia, Inc. (PHR) – Geschäftsmodell: Wertversprechen

Optimierter digitaler Check-in- und Registrierungsprozess für Patienten

Im vierten Quartal 2023 verarbeitete Phreesia 130 Millionen Patientenaufnahmen in über 2.500 Gesundheitsorganisationen. Die digitale Check-in-Plattform reduziert die durchschnittliche Patientenregistrierungszeit von 15 Minuten auf 3-5 Minuten.

Metrisch Wert
Gesamtzahl der Patientenbegegnungen 130 Millionen
Gesundheitsorganisationen 2,500+
Verkürzung der Registrierungszeit 75-67%

Reduzierter Verwaltungsaufwand für Gesundheitsdienstleister

Die Plattform von Phreesia automatisiert Verwaltungsaufgaben und spart Gesundheitsdienstleistern schätzungsweise zwei bis drei Stunden pro Tag bei der manuellen Bearbeitung von Papierkram.

  • Automatisierte Patientenaufnahmeformulare
  • Digitales Einwilligungsmanagement
  • Versicherungsüberprüfung in Echtzeit

Verbesserte Patientenerfahrung und -einbindung

Im Jahr 2023 zeigten die Patienteneinbindungstools von Phreesia einen Anstieg der Patientenportalnutzung um 45 % und eine Verbesserung der Patientenzufriedenheitswerte um 38 %.

Engagement-Metrik Prozentuale Verbesserung
Nutzung des Patientenportals 45%
Patientenzufriedenheitswerte 38%

Automatisierte Versicherungsüberprüfung und Zahlungseinzug

Die Plattform von Phreesia wickelte im Jahr 2023 Patientenzahlungen in Höhe von 4,2 Milliarden US-Dollar ab, mit einer Annahmequote von 92 % beim ersten Antrag und einer Verkürzung der Abrechnungszyklen um 78 %.

  • Gesamtzahlungsvolumen: 4,2 Milliarden US-Dollar
  • Anspruchsannahmequote: 92 %
  • Reduzierung der Abrechnungszykluszeit: 78 %

Umfassende Datenerfassung und Workflow-Optimierung

Die Plattform erfasst jährlich über 500 Millionen Patientendatenpunkte und ermöglicht so erweiterte Analysen und Workflow-Optimierung für Gesundheitsdienstleister.

Datenmetrik Jahresvolumen
Patientendatenpunkte 500 Millionen
Integrationsfähigkeiten Über 150 EHR-Systeme

Phreesia, Inc. (PHR) – Geschäftsmodell: Kundenbeziehungen

Digitale Self-Service-Plattform

Die digitale Plattform von Phreesia bedient über 97.000 Gesundheitsdienstleister in den Vereinigten Staaten. Die Plattform verarbeitet jährlich etwa 130 Millionen Patienteninteraktionen. Im dritten Quartal 2023 machten digitale Patientenaufnahmelösungen 94 % der gesamten Plattformnutzung des Unternehmens aus.

Plattformmetrik Daten für 2023
Gesamtheit der Gesundheitsdienstleister 97,000+
Jährliche Patienteninteraktionen 130 Millionen
Prozentsatz der Plattformnutzung 94%

Dediziertes Kundenerfolgsmanagement

Phreesia stellt 62 engagierte Kundenerfolgsmanager zur Verfügung, um Unternehmenskunden im Gesundheitswesen zu unterstützen. Die durchschnittliche Kundenbindungsrate liegt bei Unternehmenskunden bei 95 %.

Laufender technischer Support

Kennzahlen zum technischen Support ab 2023:

  • Support-Verfügbarkeit rund um die Uhr
  • Durchschnittliche Antwortzeit: 17 Minuten
  • Lösungsrate beim ersten Anruf: 87 %
  • Supportkanäle: Telefon, E-Mail, Live-Chat

Regelmäßige Produktschulungen und Webinare

Trainingsmetrik Daten für 2023
Monatliche Webinare 12
Jährliche Schulungssitzungen 144
Durchschnittliche Teilnehmer pro Webinar 85

Personalisierte Implementierungsdienste

Die Implementierungsunterstützung umfasst:

  • Individuelles Onboarding für jeden Gesundheitsdienstleister
  • Durchschnittliche Implementierungszeit: 45 Tage
  • Dedizierte Implementierungsspezialisten: 38
  • Erfolgskontrolle nach der Implementierung

Phreesia, Inc. (PHR) – Geschäftsmodell: Kanäle

Direktvertriebsteam

Im vierten Quartal 2023 bestand das Direktvertriebsteam von Phreesia aus 187 Vertriebsmitarbeitern, die sich an Gesundheitsdienstleister in den gesamten Vereinigten Staaten richteten.

Vertriebsteam-Metrik Daten für 2023
Gesamtzahl der Vertriebsmitarbeiter 187
Durchschnittliche Länge des Verkaufszyklus 98 Tage
Zielmarktsegmente Ambulante Pflege, Spezialkliniken, große Gesundheitssysteme

Konferenzen und Messen im Gesundheitswesen

Im Jahr 2023 nahm Phreesia an 42 Konferenzen zum Thema Gesundheitstechnologie und Praxismanagement teil.

  • HIMSS Globale Konferenz
  • Jahrestagung der American Medical Association
  • Konferenz der Healthcare Information and Management Systems Society

Online-Marketing und digitale Werbung

Die Ausgaben für digitale Werbung für Phreesia beliefen sich im Jahr 2023 auf 3,2 Millionen US-Dollar, wobei der Schwerpunkt auf LinkedIn, Google Ads und gezielten Plattformen für medizinisches Fachpersonal lag.

Digitaler Marketingkanal Budgetzuweisung 2023
LinkedIn-Werbung 1,1 Millionen US-Dollar
Google-Anzeigen 1,5 Millionen Dollar
Plattformen für medizinisches Fachpersonal $600,000

Partner-Empfehlungsnetzwerke

Phreesia unterhielt im Jahr 2023 64 strategische Partnerschaften mit Anbietern elektronischer Patientenakten (EHR) und Unternehmen der Gesundheitstechnologie.

  • Epic Systems-Integration
  • Partnerschaft mit der Cerner Corporation
  • Allscripts-Zusammenarbeit

Unternehmenswebsite und digitale Plattformen

Die digitalen Plattformen von Phreesia generierten im Jahr 2023 1,2 Millionen einzelne Besucher mit einer Website-Conversion-Rate von 4,7 %.

Digitale Plattformmetrik Leistung 2023
Einzigartige Website-Besucher 1,200,000
Website-Conversion-Rate 4.7%
Mobile App-Downloads 87,500

Phreesia, Inc. (PHR) – Geschäftsmodell: Kundensegmente

Ambulante Gesundheitspraxen

Im vierten Quartal 2023 betreut Phreesia rund 2.400 ambulante Gesundheitspraxen in den Vereinigten Staaten.

Übungsgröße Anzahl der Praktiken Marktdurchdringung
Kleine Praxen (1-5 Anbieter) 1,200 50%
Mittlere Praxen (6-20 Anbieter) 850 35%
Großpraxen (21+ Anbieter) 350 15%

Große Krankenhaussysteme

Phreesia unterstützt ab 2024 87 große Krankenhaussysteme, was einem Wachstum von 22 % gegenüber dem Vorjahr entspricht.

  • Jährlicher Gesamtumsatz des Krankenhaussystems: 42,6 Milliarden US-Dollar
  • Durchschnittliches Patientenaufkommen im Krankenhaussystem: 375.000 pro Jahr
  • Integrationsrate: 68 % der Zielkrankenhaussysteme

Medizinische Spezialkliniken

Der Kundenstamm der Spezialklinik beträgt im Dezember 2023 insgesamt 1.150.

Spezialtyp Anzahl der Kliniken
Dermatologie 340
Orthopädie 275
Kardiologie 210
Andere Spezialitäten 325

Notfallzentren

Phreesia betreut im Jahr 2024 620 Notfallzentren.

  • Durchschnittliche Patienteneinchecken pro Zentrum: 42.500 pro Jahr
  • Geografische Abdeckung: 47 Staaten
  • Marktanteil im Notfallversorgungssegment: 31 %

Ärztegemeinschaftspraxen

Das Kundensegment der Arztgemeinschaftspraxen umfasst ab 2024 1.050 Gruppen.

Größe der Übungsgruppe Anzahl der Gruppen Gesamtanbieter
Kleine Gruppen (2-10 Anbieter) 650 3,250
Mittlere Gruppen (11–50 Anbieter) 280 6,300
Große Gruppen (51+ Anbieter) 120 8,400

Phreesia, Inc. (PHR) – Geschäftsmodell: Kostenstruktur

Forschungs- und Entwicklungskosten

Für das Geschäftsjahr 2023 meldete Phreesia Forschungs- und Entwicklungskosten in Höhe von 73,4 Millionen US-Dollar, was 36,1 % des Gesamtumsatzes entspricht.

Geschäftsjahr F&E-Ausgaben Prozentsatz des Umsatzes
2023 73,4 Millionen US-Dollar 36.1%
2022 66,1 Millionen US-Dollar 34.2%

Wartung der Cloud-Infrastruktur und -Technologie

Phreesia stellt erhebliche Ressourcen für die Wartung der Cloud-Infrastruktur und der Technologie bereit, wobei die jährlichen Kosten auf etwa 15 bis 20 Millionen US-Dollar geschätzt werden.

  • Cloud-Hosting-Dienste
  • Netzwerkinfrastruktur
  • Sicherheits- und Compliance-Systeme
  • Upgrades der Technologieplattform

Vertriebs- und Marketingkosten

Im Geschäftsjahr 2023 beliefen sich die Vertriebs- und Marketingausgaben von Phreesia auf insgesamt 84,2 Millionen US-Dollar, was 41,5 % des Gesamtumsatzes entspricht.

Ausgabenkategorie Betrag Prozentsatz des Umsatzes
Vertrieb und Marketing 84,2 Millionen US-Dollar 41.5%

Mitarbeitervergütung

Die Gesamtvergütung der Mitarbeiter von Phreesia belief sich im Geschäftsjahr 2023 auf 132,6 Millionen US-Dollar.

  • Gehalt und Löhne: 98,4 Millionen US-Dollar
  • Aktienbasierte Vergütung: 34,2 Millionen US-Dollar
  • Gesamtzahl der Mitarbeiter: ca. 900

Kundensupport und Implementierungsdienste

Die Kosten für Kundensupport und Implementierungsdienste beliefen sich im Geschäftsjahr 2023 auf etwa 22,5 Millionen US-Dollar.

Servicekategorie Jährliche Kosten
Kundensupport 14,3 Millionen US-Dollar
Implementierungsdienste 8,2 Millionen US-Dollar

Phreesia, Inc. (PHR) – Geschäftsmodell: Einnahmequellen

Abonnementbasierte Softwarelizenzierung

Im vierten Quartal 2023 betrug der jährlich wiederkehrende Umsatz (ARR) von Phreesia 216,9 Millionen US-Dollar, was einem Wachstum von 20 % gegenüber dem Vorjahr entspricht.

Umsatztyp Jährlicher Wert Wachstumsrate
Abonnement-Softwarelizenzierung 148,6 Millionen US-Dollar 22%

Transaktionsgebühren pro Patient

Im Jahr 2023 erwirtschaftete Phreesia 67,3 Millionen US-Dollar aus transaktionsbasierten Einnahmequellen.

  • Durchschnittliche Transaktionsgebühr pro Patient: 2,15 $
  • Insgesamt verarbeitete Patienteninteraktionen: 31,3 Millionen

Implementierungs- und Onboarding-Services

Der Implementierungsumsatz für 2023 betrug 12,4 Millionen US-Dollar, mit einer durchschnittlichen Onboarding-Gebühr von 5.600 US-Dollar pro Gesundheitsdienstleister.

Datenanalyse- und Berichtsdienste

Das Datendienstsegment von Phreesia erwirtschaftete im Jahr 2023 18,7 Millionen US-Dollar, was 8,6 % des Gesamtumsatzes entspricht.

Servicetyp Jahresumsatz Prozentsatz des Gesamtumsatzes
Erweitertes Analytics-Paket 9,2 Millionen US-Dollar 4.2%
Berichtsdienste 9,5 Millionen US-Dollar 4.4%

Premium-Funktions-Upgrades

Der Umsatz mit Premium-Funktionen erreichte im Jahr 2023 22,1 Millionen US-Dollar, mit einem durchschnittlichen Upgrade-Wert von 1.750 US-Dollar pro Gesundheitsdienstleister.

  • Gesamtzahl der Premium-Feature-Kunden: 12.630
  • Upgrade-Akzeptanzrate: 38 %

Phreesia, Inc. (PHR) - Canvas Business Model: Value Propositions

For Providers: Automating patient intake to reduce administrative burden.

Phreesia, Inc. digital intake and payment processing solutions saved healthcare providers an estimated 1.1 billion pieces of paper in 2024. The platform facilitated more than 170 million patient visits in fiscal 2025, representing 1 in 7 visits across the U.S. As of the fourth quarter of fiscal year 2025 (ended January 31, 2025), Phreesia, Inc. served 4,341 Average Number of Healthcare Services Clients (AHSCs) in the quarter, with 4,203 AHSCs for the full fiscal year 2025. Revenue for fiscal year 2025 was $419.8 million, an 18% increase year-over-year.

Metric Category Value/Period Data Point
Patient Visits Facilitated (FY 2025) 170 million+ Scale of platform use
Paper Reduction (2024) 1.1 billion pieces Environmental/Administrative impact
AHSCs (Q4 FY2025) 4,341 Client count in a single quarter
Total Revenue (FY 2025) $419.8 million Annual top-line performance

For Providers: Improving cash flow via real-time insurance verification and payment collection.

The system supports over 1,000 payers, including all state Medicaid programs. Automated verification is shown to cut claim denials by about 20%. Phreesia, Inc. crossed over to positive Free Cash Flow in the fiscal second quarter of 2025. For the fiscal year ended January 31, 2025, Adjusted EBITDA reached $36.8 million, a significant improvement from negative $35.4 million in fiscal year 2024. For the fourth quarter of fiscal year 2025, Free Cash Flow was $9.2 million.

For Patients: Convenient, mobile-friendly digital check-in and payment options.

The platform offers patient-driven digital solutions for intake, outreach, and education. Phreesia, Inc. has an overall rating of 4.3 out of 5 on Capterra, based on direct client feedback as of August 2025.

  • Digital check-in options include mobile and tablet use.
  • Payment processing capabilities are integrated into the workflow.
  • Enhances patient experience and drives efficiency.

For Life Sciences: Direct patient engagement for clinical trial recruitment and adherence.

Phreesia, Inc. gives life sciences companies tools to help patients take a more active role in their care. While specific recruitment metrics aren't detailed in the latest reports, the platform's scale of 1 in 7 U.S. patient visits provides a broad base for engagement.

For Patients/Providers: Offering patient financing for healthcare receivables.

Phreesia, Inc. entered a definitive agreement to acquire AccessOne, a market leader in financing solutions for healthcare receivables. AccessOne currently manages a receivables portfolio of approximately $450 million. This transaction is expected to expand Phreesia, Inc.'s addressable market by roughly $6 billion. The deal was a $160 million transaction.

Phreesia, Inc. (PHR) - Canvas Business Model: Customer Relationships

You're managing a relationship with a healthcare system, and you need to know how Phreesia, Inc. keeps its B2B clients locked in. It's not just about the software; it's about the structure of that ongoing connection. The core relationship is built on long-term commitments to their SaaS platform, which handles everything from initial patient contact to final payment processing.

For high-touch B2B client relationships, Phreesia, Inc. structures its engagement around consistent growth and service. As of the fiscal second quarter ended July 31, 2025, the company served an average of 4,467 Average Healthcare Services Clients (AHSCs). This represents a 7% year-over-year increase in the client base for that quarter. The total addressable market for Phreesia, Inc. in the U.S. for ambulatory and hospital settings is estimated at approximately 50,000 healthcare services clients. This suggests significant room for expansion within the existing client relationship model.

The stickiness of these relationships is reflected in the recurring revenue metrics. For the fiscal second quarter ended July 31, 2025, the total revenue per AHSC reached $26,249. This shows a 7% year-over-year improvement in the value extracted per client relationship for that period. The company's strategy involves continuous product updates and customer support for the SaaS platform. This commitment is recognized by the industry; Phreesia, Inc. was named a 2025 Top-Rated Vendor for Patient Registration and Intake Solutions in Revenue Cycle Management by Black Book Research, an award based on survey responses collected from over 11,500+ healthcare finance professionals, administrators, and RCM specialists.

Self-service digital tools are central to the patient-driven side of the relationship, which directly impacts the provider client's efficiency. Phreesia, Inc. enabled approximately 170 million patient visits in 2024, which was over 1 in 7 patient visits across the U.S.. The patient self-service solution includes electronic payment applications, clinical and administrative data collection, and consent form management.

Long-term subscription contracts form the backbone of revenue stability. The platform offers a robust suite of integrated solutions managing patient access, registration, payments, and clinical support through its SaaS-based technology platform.

Continuous product updates and customer support are essential for maintaining these long-term SaaS agreements. Phreesia, Inc.'s healthcare payment solutions come with robust customer support, featuring dedicated teams that work 24/7 to monitor payment workflows, ensuring rapid assistance is available. The platform itself includes tools for transforming patient experience management, such as analytics dashboards to track sentiment and satisfaction scores, and engagement automation for pre-visit and post-visit communication.

Here's a look at how the client base and revenue per client have trended:

Metric Q2 FY2026 (Jul 31, 2025) Q1 FY2026 (Apr 30, 2025) FY 2024 (Actual)
Average Healthcare Services Clients (AHSCs) 4,467 4,411 3,601
Total Revenue per AHSC $26,249 $26,283 $98,944 (Full Year)
YoY AHSC Growth Rate 7% 9% N/A

The relationship management strategy supports ongoing patient engagement across the entire journey:

  • Pre-visit engagement via online scheduling and digital check-ins.
  • During the visit with digital intake forms and consent management.
  • Post-visit follow-up through automated surveys and educational content.
  • Ongoing communication to reinforce provider-patient trust.

Finance: draft 13-week cash view by Friday.

Phreesia, Inc. (PHR) - Canvas Business Model: Channels

You're looking at how Phreesia, Inc. gets its platform in front of its customers-the actual delivery mechanism. This is where the rubber meets the road, turning strategy into signed contracts and patient interactions. The channels are a mix of high-touch direct sales and scalable digital adoption.

Direct Enterprise Sales Force Targeting Large Health Systems and Hospitals

The core of landing large accounts, like major health systems, relies on a dedicated direct sales force. This team is responsible for navigating complex procurement cycles. While the exact size of the sales team isn't broken out, Phreesia, Inc. had a total of 2,082 employees as of August 29, 2025, indicating the scale of the organization supporting these efforts. Growth in the client base is a direct reflection of this channel's success; the company expected its Average Number of Healthcare Services Clients (AHSCs) to reach approximately 4,200 for the full fiscal year 2025, up from 3,601 in fiscal 2024. The focus is clearly on driving up Total Revenue per AHSC, which was $25,207 in the third quarter ended October 31, 2024, showing the value extracted post-sale.

The sales motion is structured to build pipeline efficiency:

  • Marketing identifies customer profiles and deploys one-to-many communications.
  • The sales development team creates and qualifies opportunities.
  • The direct sales team executes on these qualified leads.

Integrations with Major EHR/EMR Systems for Seamless Workflow Adoption

Workflow adoption hinges on making the platform feel native within the provider's existing technology stack. Phreesia, Inc. emphasizes its integration capabilities as a key driver for reducing friction and ensuring patient data flows smoothly. The platform seamlessly integrates with over 80 leading practice management systems. While the exact number of supported Electronic Health Record (EHR) systems isn't explicitly stated, the focus on integration is critical, as nearly 89% of healthcare finance professionals reported that delays or inaccuracies in front-end processes directly impacted cash flow and claim denials in 2024. The company also made strategic acquisitions, like ConnectOnCall, to specifically enhance call-triaging efficiency, which ties directly into the front-end workflow.

Web and Mobile Applications for Patient-Facing Interactions

This is the consumer-facing channel, where the platform touches the patient directly. The scale here is massive, which is a key differentiator. Phreesia, Inc. enabled approximately 170 million patient visits in 2024, representing about 1 in 7 visits across the U.S. The platform delivers personalized health content when patients are in a healthcare state of mind, which research suggests 71% of consumers expect. This channel spans digital intake before an appointment, education during the visit, and outreach post-appointment, including prompting patients toward their pharmacy, where almost 23% of patients surveyed have used an online service.

Here's a look at the scale and financial impact of the client base driving these interactions:

Metric Q3 FY2025 (Ended Oct 31, 2024) FY 2024 Actual FY 2026 Expectation
Average Healthcare Services Clients (AHSCs) 4,237 3,601 Approx. 4,500
Total Revenue per AHSC (Annualized Run Rate) $25,207 $98,944 Expected to Increase from FY 2025
Total Patient Visits Enabled (Annual) N/A (Approx. 170M in 2024) Approx. 170 million Implied Growth from Revenue Outlook

Industry Conferences and Digital Marketing Campaigns

Marketing efforts support the direct sales channel by building brand awareness and preparing the market for engagement. The process involves the marketing team identifying customer profiles and deploying one-to-many communications to 'soften the market.' This preparatory work helps the sales development team engage more effectively with prospective customers. Furthermore, Phreesia, Inc.'s recognition as the 2025 Top-Rated Vendor for Patient Registration and Intake Solutions by Black Book Research, based on feedback from over 11,500 healthcare finance professionals, validates the effectiveness of their market presence and messaging delivered through these awareness channels.

Phreesia, Inc. (PHR) - Canvas Business Model: Customer Segments

Phreesia, Inc. serves a broad spectrum of healthcare entities, targeting a total addressable market (TAM) estimated at approximately $24 billion as of mid-2025.

The core client base is categorized as Healthcare Services Clients (AHSCs), which reached 4,203 for the fiscal year ended January 31, 2025, growing to 4,467 by July 31, 2025.

Metric Fiscal Year Ended Jan 31, 2025 (FY2025) Q2 Fiscal 2026 (Ended Jul 31, 2025)
Average Healthcare Services Clients (AHSCs) 4,203 4,467
Total Revenue per AHSC $99,884 $26,249 (Quarterly)
Healthcare Services Revenue per AHSC $70,961 N/A
Total Revenue $419.8 million $117.3 million (Quarterly)

The customer base is diverse, spanning over 25 specialties, and includes large systems, smaller practices, and other organizations.

The revenue mix as of the second quarter of fiscal 2026 reflects the relative engagement across different client types:

  • Subscription and related services: 46% of Q2 FY2026 revenue.
  • Payment processing fees: 24% of Q2 FY2026 revenue.
  • Network solutions: 30% of Q2 FY2026 revenue.

Large Hospitals and Integrated Health Systems (anchor clients).

These anchor clients contribute to the overall base of 4,203 AHSCs in FY2025, with the company serving large multi-specialty groups.

Physician Practices and Clinics of varying sizes across the US.

This segment includes single-specialty practices, primary care groups, and ambulatory surgery centers, all contributing to the 4,467 AHSCs reported in Q2 FY2026.

Life Sciences and Pharmaceutical Companies (for Network Solutions).

This customer group drives the Network Solutions revenue stream, which represented 30% of total revenue in Q2 FY2026. The TAM for Network Solutions is listed at $8.2 billion.

Healthcare Payers and Insurance Organizations.

Phreesia, Inc. serves payers and other organizations, alongside providers and life sciences companies, to help patients take a more active role in their care. The company enabled approximately 170 million patient visits in 2024.

Phreesia, Inc. (PHR) - Canvas Business Model: Cost Structure

You're looking at the expenses that drive Phreesia, Inc.'s operations as of late 2025. Honestly, for a high-growth software and payments platform, the cost structure is dominated by scaling the technology, acquiring new clients, and handling the transaction volume.

The Cost of Revenue is a significant component, reflecting the direct costs of delivering the platform and processing payments. For the fiscal year ended January 31, 2025, the Cost of revenue (excluding depreciation and amortization) was $66.2 million. This figure increased by 9 percent, or $5.2 million, over the prior fiscal year, driven primarily by a $7.7 million increase in other third-party costs tied to revenue growth, though this was partially offset by a $2.5 million decrease in associated labor costs for that full year period.

Payment processing expenses are a key part of this, given the volume of patient payments handled. For the three months ended July 31, 2025 (Q2 FY2026), the Payment processing expense was $20.2 million, up $3.6 million from the $16.7 million recorded in the same period in the prior year. To be fair, the payment processing take rate percentage was noted as 2.8% in Q2 FY2026, down from 2.9% in Q2 FY2025, which puts pressure on the profitability of that segment.

Investment in Research and Development (R&D) shows the commitment to building out the platform. While a specific total R&D dollar amount for the latest quarter isn't immediately clear, we do see that stock compensation incurred related to R&D expense for the three months ended July 31, 2025, was $4.2 million. Management noted that R&D expense decreased sequentially because certain tools were repurposed for revenue-generating activities.

Sales and Marketing (S&M) expenses are substantial for client acquisition and expansion. For the third quarter of fiscal 2025 (ended October 31, 2024), S&M expenses represented about 28% of revenue. In absolute terms for the three months ended July 31, 2025, Sales and marketing expense was $25.4 million, a decrease of $4.8 million from $30.2 million in the prior year's comparable quarter. This decrease was mainly due to a $6.2 million drop in labor costs, partially offset by a $1.4 million rise in other third-party sales and marketing costs.

Personnel costs are embedded across the operating structure, particularly in technology, sales, and client support, which are critical for service delivery and growth. The labor cost component within Cost of Revenue saw a $1.6 million decrease for the three months ended July 31, 2025, year-over-year. The focus on operating leverage is evident here, as the company achieved positive free cash flow of $3.7 million in the quarter ending July 31, 2025, compared to negative $2.2 million in the same period of the prior year.

General and administrative (G&A) overhead reflects the costs of running a publicly traded company. For the three months ended July 31, 2025, General and administrative expense was $19.0 million, a slight decrease from $19.5 million in the same period of fiscal 2024.

Here's a snapshot of some of the key expense line items for the most recent reported quarter (Q2 FY2026, three months ended July 31, 2025) versus the prior year period, alongside the specified S&M ratio:

Cost Component Period Amount (USD Millions)
Cost of Revenue (excl. D&A) 3 Months Ended July 31, 2025 $17.4
Payment Processing Expense 3 Months Ended July 31, 2025 $20.2
Sales and Marketing Expense 3 Months Ended July 31, 2025 $25.4
Sales and Marketing Expense as % of Revenue Q3 FY2025 28%
General & Administrative Expense 3 Months Ended July 31, 2025 $19.0
R&D Stock Compensation Expense 3 Months Ended July 31, 2025 $4.2

You can see the focus on expense discipline helping to drive operating leverage, especially in S&M and G&A relative to revenue growth.

The structure of these costs points to a business model where variable costs tied to transaction volume (payment processing) and fixed/semi-fixed costs for platform development (R&D) and client acquisition (S&M) are the primary drivers.

  • High third-party costs within Cost of Revenue are directly scaling with platform usage.
  • Labor costs are being actively managed for efficiency across Cost of Revenue and S&M.
  • G&A remains relatively stable quarter-over-quarter, suggesting overhead is being absorbed by higher revenue.
  • Stock-based compensation is a non-cash cost present in both R&D and Cost of Revenue.

Finance: draft 13-week cash view by Friday.

Phreesia, Inc. (PHR) - Canvas Business Model: Revenue Streams

The Revenue Streams for Phreesia, Inc. (PHR) are built on three primary pillars, all scaling with the growth of their Average Healthcare Services Clients (AHSCs).

Subscription Fees (SaaS) for platform access and modules represent a core, recurring element of the revenue base. For the Fiscal Year 2025, Subscription and related services revenue was reported as $196,510 thousand.

Payment Processing Fees (transaction-based revenue) scale directly with patient payment volume. This stream generated $101,740 thousand in revenue for Fiscal Year 2025. The growth in this segment was impacted by the wind-down of a clearinghouse client relationship, which negatively impacted year-over-year payment processing fees revenue growth by approximately 7% in Q3 2025.

Network Solutions Revenue (advertising/engagement from Life Sciences/Payers) is a high-growth component derived from engaging patients through the platform. This stream grew 27% year-over-year in Q3 2025. For the full Fiscal Year 2025, Network solutions revenue reached $121,563 thousand.

Here's a look at the disaggregated revenue streams for the full Fiscal Year 2025:

Revenue Stream FY 2025 Revenue (in thousands USD) Q3 FY2025 YoY Growth Rate
Subscription and related services $196,510 16%
Payment processing fees $101,740 6%
Network solutions revenue $121,563 27%

The Total Revenue for Fiscal Year 2025 was $419.8 million. This figure is supported by the reported total revenue of $419,813 thousand for the year ended January 31, 2025.

Looking ahead, the Fiscal Year 2026 revenue guidance is $472 million to $482 million. This guidance is introduced with an expectation for Total revenue per AHSC to increase in fiscal 2026 compared to fiscal 2025.

The composition of revenue streams, based on Q2 FY2026 reporting, shows the relative weighting:

  • Subscription and related services: 46% of Q2 FY2026 revenue.
  • Payment processing fees: 24% of Q2 FY2026 revenue.
  • Network solutions: 30% of Q2 FY2026 revenue.

For Q3 2025, Subscription and related services revenue per AHSC was $11,650, showing a 1% year-over-year increase.

Finance: review the impact of the clearinghouse wind-down on Q4 2025 payment processing fee projections by Tuesday.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.